Your browser doesn't support JavaScript. Please upgrade to a modern browser or enable JavaScript in your existing browser.
Skip Navigation U.S. Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
Archive print banner

This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.

Please go to www.ahrq.gov for current information.

Figure 3. Screening and Treating Adults for Lipid Disorders: Methods

Screening for lipid disorders: analytic framework and key questions. Numbers refer to key questions (KQ) as follows: KQ 1. What is the accuracy of screening for detecting persons at increased risk of CHD because of abnormal lipids? KQ 2. What is the effectiveness of diet therapy or exercise or drug therapy in reducing the incidence of mortality from CHD in asymptomatic people with abnormal lipids? KQ3. What are the adverse effects of screening? KQ4. What are the adverse effects of diet or drug treatment?

Return to Document

 

The information on this page is archived and provided for reference purposes only.

 

AHRQ Advancing Excellence in Health Care